Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annick Barbaud

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Current Pharmaceutical Design|October 26, 2016
Genetic Predictors of Drug HypersensitivityJose A Cornejo-Garcia, Abderrahim Oussalah, Miguel Blanca, et al.
Journal of the American Academy of Dermatology|May 23, 2020
Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patientsRomain Salle, François Chasset, Diane Kottler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 24, 2021
DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case SeriesAngèle Soria, Emmanuelle Amsler, Claire Bernier, et al.
Frontiers in Pediatrics|July 25, 2022
Linear Immunoglobulin a Bullous Dermatosis in ChildrenFrancesca Mori, Francesca Saretta, Lucia Liotti, et al.
Journal of the American Academy of Dermatology|August 1, 2021
Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patientsGabrielle Sonigo, Marie Jachiet, Didier Bessis, et al.
Allergy|December 29, 2023
EAACI/ENDA position paper on drug provocation testingAnnick Barbaud, Lene Heise Garvey, Maria Torres, et al.
Journal of the American Academy of Dermatology|January 24, 2025
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patientsQuitterie Murat de Montai, Clémence Masseran, Laura Perray, et al.
Allergy|November 28, 2023
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paperSevim Bavbek, Seçil Kepil Özdemir, Patrizia Bonadonna, et al.
Allergy|March 27, 2023
Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactionsAngèle Soria, Marina Labella, Inmaculada Doña, et al.
Journal of the American Academy of Dermatology|February 1, 2024
Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patientsClémence Masseran, Laura Perray, Quitterie Murat de Montai, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Current Pharmaceutical Design|October 26, 2016
Genetic Predictors of Drug HypersensitivityJose A Cornejo-Garcia, Abderrahim Oussalah, Miguel Blanca, et al.
Journal of the American Academy of Dermatology|May 23, 2020
Belimumab for refractory manifestations of cutaneous lupus: A multicenter, retrospective observational study of 16 patientsRomain Salle, François Chasset, Diane Kottler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 24, 2021
DRESS and AGEP Reactions to Iodinated Contrast Media: A French Case SeriesAngèle Soria, Emmanuelle Amsler, Claire Bernier, et al.
Frontiers in Pediatrics|July 25, 2022
Linear Immunoglobulin a Bullous Dermatosis in ChildrenFrancesca Mori, Francesca Saretta, Lucia Liotti, et al.
Journal of the American Academy of Dermatology|August 1, 2021
Hydroxychloroquine dose tapering or discontinuation in cutaneous lupus erythematosus after remission: A retrospective multicenter cohort study of 56 patientsGabrielle Sonigo, Marie Jachiet, Didier Bessis, et al.
Allergy|December 29, 2023
EAACI/ENDA position paper on drug provocation testingAnnick Barbaud, Lene Heise Garvey, Maria Torres, et al.
Journal of the American Academy of Dermatology|January 24, 2025
Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: A monocentric study of 184 patientsQuitterie Murat de Montai, Clémence Masseran, Laura Perray, et al.
Allergy|November 28, 2023
Hypersensitivity reactions to proton pump inhibitors. An EAACI position paperSevim Bavbek, Seçil Kepil Özdemir, Patrizia Bonadonna, et al.
Allergy|March 27, 2023
Risk stratification through extensive allergy work-up in COVID-19-mRNA vaccine allergic reactionsAngèle Soria, Marina Labella, Inmaculada Doña, et al.
Journal of the American Academy of Dermatology|February 1, 2024
Comparison of patients with isolated cutaneous lupus erythematosus versus systemic lupus erythematosus with cutaneous lupus erythematosus as the sole clinical feature: A monocentric study of 149 patientsClémence Masseran, Laura Perray, Quitterie Murat de Montai, et al.
Pageof 16